Artivion, a medical device company that manufactures implantable tissues for cardiac and vascular transplant applications, has announced that its services have been “disrupted” due to a cybersecurity incident.
In an 8-K filing with the SEC on Monday, Georgia-based Artivion, formerly CryoLife, disclosed that it discovered a “cybersecurity incident” involving the “acquisition and encryption” of data on November 21. This indicates a possible ransomware attack, although Artivion has not confirmed the exact nature of the incident and has not responded to inquiries from TechCrunch. As of now, no prominent ransomware group has claimed responsibility for the breach.
In response to the cyberattack, Artivion took certain systems offline, resulting in “disruptions to some order and shipping processes”.
Despite reporting third-quarter revenues of $95.8 million, Artivion stated that it does not anticipate a significant impact on the company’s financials as a result of the incident.
